The nigrostriatal system in Parkinson's disease - PubMed (original) (raw)
Affiliations
- PMID: 1978514
Review
The nigrostriatal system in Parkinson's disease
A M Graybiel et al. Adv Neurol. 1990.
Abstract
Patterns of dopaminergic cell loss in the midbrain and patterns of mesostriatal fiber loss in the caudate nucleus and putamen are described for cases of idiopathic Parkinson's disease. Neither cell loss nor fiber loss is homogeneous. In the midbrain, quantitative analysis points to a selective vulnerability of neurons in the most heavily pigmented dopaminergic cell groups. In the striatum, a dorsolateral-to-ventromedial gradient of loss appears to characterize both the caudate nucleus and the putamen. These patterns of loss and sparing have implications both for analysis of the clinical symptoms of Parkinson's disease and for study of the etiology of this disease.
Similar articles
- Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms.
Hornykiewicz O. Hornykiewicz O. Adv Neurol. 1993;60:140-7. Adv Neurol. 1993. PMID: 8420131 Review. No abstract available. - [Neurobiologic and pharmacologic studies on the pathogenesis of Parkinson disease].
Brücke T, Riederer P. Brücke T, et al. Wien Med Wochenschr. 1986 Aug 31;136(15-16):401-8. Wien Med Wochenschr. 1986. PMID: 2878540 German. - Second messenger systems in brains of patients with Parkinson's or Huntington's disease.
Tanaka C, Nishino N, Hashimoto T, Kitamura N, Yoshihara C, Saito N. Tanaka C, et al. Adv Neurol. 1993;60:175-80. Adv Neurol. 1993. PMID: 8093576 - Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease.
Anglade P, Tsuji S, Javoy-Agid F, Agid Y, Hirsch EC. Anglade P, et al. Ann Neurol. 1995 Feb;37(2):265-72. doi: 10.1002/ana.410370219. Ann Neurol. 1995. PMID: 7847868 - Pathogenesis and animal studies of Parkinson's disease.
Oertel WH, Kupsch A. Oertel WH, et al. Curr Opin Neurol Neurosurg. 1993 Jun;6(3):323-32. Curr Opin Neurol Neurosurg. 1993. PMID: 8507901 Review.
Cited by
- Midbrain organoids-development and applications in Parkinson's disease.
Toh HSY, Choo XY, Sun AX. Toh HSY, et al. Oxf Open Neurosci. 2023 Aug 18;2:kvad009. doi: 10.1093/oons/kvad009. eCollection 2023. Oxf Open Neurosci. 2023. PMID: 38596240 Free PMC article. Review. - The assessment of executive functions to test the integrity of the nigrostriatal network: A pilot study.
Ilardi CR, di Maio G, Villano I, Messina G, Monda V, Messina A, Porro C, Panaro MA, Gamboz N, Iavarone A, La Marra M. Ilardi CR, et al. Front Psychol. 2023 Mar 29;14:1121251. doi: 10.3389/fpsyg.2023.1121251. eCollection 2023. Front Psychol. 2023. PMID: 37063521 Free PMC article. - Neuropathology of the Basal Ganglia in SNCA Transgenic Rat Model of Parkinson's Disease: Involvement of Parvalbuminergic Interneurons and Glial-Derived Neurotropic Factor.
Paldino E, D'angelo V, Massaro Cenere M, Guatteo E, Barattucci S, Migliorato G, Berretta N, Riess O, Sancesario G, Mercuri NB, Fusco FR. Paldino E, et al. Int J Mol Sci. 2022 Sep 4;23(17):10126. doi: 10.3390/ijms231710126. Int J Mol Sci. 2022. PMID: 36077524 Free PMC article. - Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein.
Patterson JR, Hirst WD, Howe JW, Russell CP, Cole-Strauss A, Kemp CJ, Duffy MF, Lamp J, Umstead A, Kubik M, Stoll AC, Vega IE, Steece-Collier K, Chen Y, Campbell AC, Nezich CL, Glajch KE, Sortwell CE. Patterson JR, et al. NPJ Parkinsons Dis. 2022 May 24;8(1):61. doi: 10.1038/s41531-022-00322-x. NPJ Parkinsons Dis. 2022. PMID: 35610264 Free PMC article. - Alpha-synucleinopathy reduces NMNAT3 protein levels and neurite formation that can be rescued by targeting the NAD+ pathway.
Parsons RB, Kocinaj A, Ruiz Pulido G, Prendergast SA, Parsons AE, Facey PD, Hirth F. Parsons RB, et al. Hum Mol Genet. 2022 Aug 25;31(17):2918-2933. doi: 10.1093/hmg/ddac077. Hum Mol Genet. 2022. PMID: 35397003 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical